Centre National de Référence VHA VHE http://www.cnrvha-vhe.org Centre National de Référence des virus des hépatites à transmission entérique Wed, 08 Apr 2026 16:20:37 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 Publications 2019-2020 http://www.cnrvha-vhe.org/?p=131299 http://www.cnrvha-vhe.org/?p=131299#comments Tue, 26 Apr 2022 08:32:51 +0000 Toulouse http://www.cnrvha-vhe.org/?p=131299 HEPATITE A

1- Gallian P, Barlet V, Mouna L, Gross S, Morel P, Le Cam S, Ricard C, Maugard C, Pouchol E, Flan B, Visse C, Djoudi R, Figoni J, De Valk H, Tiberghien P, Roque-Afonso AM. Persisting higher prevalence of hepatitis A virus RNA in blood donors, France, 2018. Euro Surveill. 2019 Nov;24(47):1900695

2-Izquierdo L, Mellon G, Buchaillet C, Fac C, Soutière MP, Pallier C, Dulioust A, Roque-Afonso AM.PLoS One. 2019 Jun 26;14(6):e0218482.Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates. Izquierdo L, Mellon G, Buchaillet C, Fac C, Soutière MP, Pallier C, Dulioust A, Roque-Afonso AM.PLoS One. 2019 Jun 26;14(6):e0218482.

3-Abi Nader E, Girard M, Leruez-Ville M, Sissaoui S, Lacaille F, Roque-Afonso AM, Debray Seroprevalence of Hepatitis E virus infection in children after liver transplantation: A single-center experience in France. D.Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):174-180.

4-Guillaume M, Mouna L, Coustillères F, Lemée V, Roque-Afonso AM, Mourez T, Lefaucheur R.  Invasive meningoencephalitis as the first manifestation of hepatitis A. .J Viral Hepat. 2019 Nov;26(11):1330-1333

5-Enkirch T, Severi E, Vennema H, Thornton L, Dean J, Borg ML, Ciccaglione AR, Bruni R, Christova I, Ngui SL, Balogun K, Němeček V, Kontio M, Takács M, Hettmann A, Korotinska R, Löve A, Avellón A, Muñoz-Chimeno M, de Sousa R, Janta D, Epštein J, Klamer S, Suin V, Aberle SW, Holzmann H, Mellou K, Ederth JL, Sundqvist L, Roque-Afonso AM, Filipović SK, Poljak M, Vold L, Stene-Johansen K, Midgley S, Fischer TK, Faber M, Wenzel JJ, Takkinen J, Leitmeyer K. Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus. Euro Surveill. 2019 Jul;24(28):1800397

6- Nicolay N, Le Bourhis-Zaimi M, Lesourd A, Martel M, Roque-Afonso AM, Erouart S, Etienne M, Ndeikoundam Ngangro N. A description of a hepatitis A outbreak in men who have sex with men and public health measures implemented in Seine-Maritime department, Normandy, France, 2017.BMC Public Health. 2020 Sep 22;20(1):1441

 

HEPATITE E

1-       Marion O, Abravanel F, Izopet J, Kamar N. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 Jan 21:e13050.

2-       Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, Kamar N, Izopet J. Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients. J Infect. 2019 Mar;78(3):232-240.

3-       Marion O, Lhomme S, Abravanel F, Izopet J, Kamar N.Should 12 or 24 weeks post-ribavirin follow-up be considered to define sustained virological response in transplant-patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 Mar 12:e13065.

4-       Abravanel F, Goutagny N, Joffray R, Eichenlaub E, Baron S, Aversenq A, Bourg S, Mercier L, Larue Triolet A, Poirault D, Loubet M, Daniel S, Luciani F, Pothion C, Tourneur C, Dugua JM, Lhomme S, Izopet J. Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.J Clin Virol. 2019 Mar;112:10-14

5-       Marion O, Lhomme S, Del Bello A, Abravanel F, Esposito L, Hébral AL, Lavayssière L, Cointault O, Ribes D, Izopet J, Kamar N. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 Jan;70(1):206-209.

6-       Capelli N, Marion O, Dubois M, Allart S, Bertrand-Michel J, Lhomme S, Abravanel F, Izopet J, Chapuy-Regaud S.Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes. J Virol. 2019 Feb 5;93(4).

7-       S. Lhomme, F. Abravanel, N. Kamar, J. Izopet. Screening, diagnosis and risks associated with Hepatitis E infection. Expert Review of Anti-Infective Therapy 2019;17:403-418.

8-       C. Diméglio, D. Kania, J. Mbombi Mantono, T. Kagoné, S. Zida, S. Tassembedo, A. Dicko, B. Tinto, S. Yaro, H. Hien, J. Rouamba, B. Bicaba, I. Medah, N. Meda, O. Traoré, E. Tuaillon, F. Abravanel, J. Izopet. Hepatitis E virus infections among patients with acute febrile jaundice in Burkina Faso. Viruses 2019;554:1-9.

9-       J. Izopet, P. Trémeaux, O. Marion, M. Migueres, N. Capelli, S. Chapuy-Regaud, JM. Mansuy, F. Abravanel, N. Kamar, S. Lhomme. Hepatitis E virus infections in Europe. Journal of Clinical Virology 2019;120:20-26.

10-    P. Gallian, E. Pouchol, R. Djoudi, S. Lhomme, L. Mouna, S. Gross, P. Bierling, A. Assal, N. Kamar, V. Mallet, AM. Roque-Afonso, J. Izopet, P. Tiberghien. Transfusion-transmitted hepatitis E virus infection in France. Transfusion Medicine Reviews 2019;33:146-153.

11-    S. Lhomme, S. DebRoy, N. Kamar, F. Abravanel, D. Metsu, O. Marion, C. Dimeglio, SJ. Cotler, J. Izopet, H. Dahari. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses  2019;11:7.

12-    S. Lhomme, P. Gallian, C. Diméglio, F. Abravanel, P. Tiberghein, J. Izopet. Viral load and clinical manifestations of hepatitis E virus genotype 3 infections. J  Viral Hepatitis 2019;26:1139-1142.

13-    IM. Sayed, L. Verhoye, C. Montpellier, F. Abravanel, J. Izopet, L. Cocquerel, P. Meuleman. Study of hepatitis E virus ORF2 antigen kinetics in human-liver chimeric mice and its impact on HEV diagnosis. Journal of Infectious Diseases 2019;220:811-819.

14-    A. Del Bello, F. Abravanel, L. Alric, L. Lavayssière, S. Lhomme, J. Bellière, J. Izopet, N. Kamar. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents. Transplant Infectious Disease 2019;21:e13093.

15-    A. Xhaard, AM. Roque-Afonso, V. Mallet, P. Ribaud, S. Nguyen-Quoc, PS. Rohrlich, R. Tabrizi, J. Konopacki, S. Lissandre, F. Abravanel, RP. Latour, A. Huynh. Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study. Viruses 2019;11(7).

16-    Protin, F. Abravanel, L. Alric, S. Tavitian, L. Obéric, J. Izopet, G. Martin-Blondel, L. Ysebaert. Ribavirin for chronic Hepatitis E virus infection in ibrutinib-exposed patients. Open Forum Infect Dis 2019;6:ofz345.

17-    I.B. Olsoy, S. Henriksen, F.H. Weissbach, M. Larsen, K. Borgen, F. Abravanel, N. Kamar, E.J. Paulssen, H.H. Hirsch, C.H. Rinaldo. Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromso study. Med Microbiol Immunol, 2019, 208 :715-725

18-    N. Capelli, M. Dubois, M. Pucelle, I. Da Silva, S. Lhomme, F. Abravanel, S. Chapuy-Regaud, J. Izopet. Optimized HEV culture and its application to measurements of HEV infectivity. Viruses 2020;12:1-11.

19-    S. Lhomme, O. Marion, F. Abravanel, J. Izopet, N. Kamar. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. Journal of Clinical Medicine 2020;9:1-25.

20-    A. Yrondi, J. Salles, JM. Péron, M. Sporer, S. Taib, A. Gallini, C. Noilhan, C. Dimeglio, F. Entajan, M. Crequy, J. Izopet, L. Schmitt. The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior. Front Psychiatry. 2019;10:832.

21-    L. Capai, N. Hozé, J. Chiaroni, S. Gross, R. Djoudi, R. Charrel, J. Izopet, S. Priet, S. Cauchemez, X. De Lamballerie, A. Falchi, P. Gallian. Seroprevalence and quantification of antibodies anti-HEV IgG among blood donors in Corsica, France, 2017. Eurosurveillance 2020; 25:pii=1900336.

22-    H. Larrue, F. Abravanel, JM. Péron. Hepatitis E, what’s the real issue? Liver International 2020;Suppl 1:43-47.

23-    S. Lhomme, F. Nicot, N. Jeanne, A. Roulet, C. Lefèbvre, R. Carcenac, M. Manno, M. Dubois, JM. Péron, L. Alric, N. Kamar, F. Abravanel, J. Izopet. Insertions and duplications in the polyproline region of the hepatitis E virus. Frontiers in Microbiology 2020;11:1.

24-    F. Abravanel, C. Diméglio, M. Castanier, JM. Péron, N. Kamar, S. Lhomme, J. Izopet on behalf of the HEV study group. Does HEV-3 subtype play a role in the severity of acute hepatitis E? Liver International 2020;40:333-337.

25-    N. Kamar, F. Abravanel, P. Behrendt, J. Hofmann, GP. Pageaux, C. Barbet, V. Moal, L. Couzi, T. Horvatits, RA. De Man, E. Cassuto, AM. Elsharkawy, A. Riezebos-Brilman, A. Scemla, S. Hillaire, MC. Donnely, S. Radenne, J. Sayegh, C. Garrouste, J. Dumortier, F. Glowaki, M. Matignon, A. Coilly, L. Figueres, C. Mousson, A. Minello, S. Dharancy, JP. Rerolle, P. Lebray, I. Etienne, P. Perrin, M. Choi, O. Marion, J. Izopet. Ribavirin for hepatitis E virus infection after organ transplantation: a large European retrospective multicenter study. Clinical Infectious Diseases 2020,;71:1204-1211

26-    O. Marion, S. Lhomme, M. Nayrac, M. Dubois, M. Pucelle, M. Requena, M. Migueres, F. Abravanel, JM. Péron, N. Carrère, B. Suc, P. Delobel, N. Kamar, J. Izopet. Hepatitis E virus replication in human intestinal cells. Gut, 2020; 69:901-910

27-    A. Belbézier, A. Deroux, F. Sarrot-Reynault, B. Colombe, A. Bosseray, C. Winternberger, P. Dumanoir, M. Lugosi, I. Boccon-Gibod, V. Leroy, M. Maignan, R. Collomb-Muret, D. Viglino, M. Vaillant, L. Minotti, E. Lagrange, O. Epaulard, C. Dumestre-Perard, S. Lhomme, J. Lupo, S. Larrat, P. Morand, C. Schwebel, A. Vilotitch, JL. Bosson, L. Bouillet. Screening of hepatitis E in patients presenting for acute neurological disorders. J Infect Public Health 2020;13:1047-1050.

28-    S. Lhomme, F. Abravanel, M. Migueres, N. Kamar, J. Izopet. Hepatitis E virus: how to escape the host innate immunity? Vaccines 2020;8:E422.

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=131299 0 Publications 2018 http://www.cnrvha-vhe.org/?p=131295 http://www.cnrvha-vhe.org/?p=131295#comments Tue, 26 Apr 2022 08:30:51 +0000 Toulouse http://www.cnrvha-vhe.org/?p=131295 1-       E Couturier, L Mouna, MJ Letort, D Van Cauteren, AM Roque-Afonso, H De Valk. Dix premières années de surveillance de l’Hépatite A par la déclaration obligatoire, France 2006-2015. Bull Epidémiol Hebd. 2018 ; (5) :68-77.

2-       L Mouna, E Bouthry, AM Roque-Afonso. Epidémiologie et diagnostic de l’hépatite A; Feuillets de Biologie 2018. N° 344 3.AM Roque-Afonso. Les enjeux de la vaccination contre l’hépatite A. Rev Prat. 2018. Tome 68_N°3 : 291-2.

3-       M Guillaume, L Mouna, F Coustillères, V Lemée, AM Roque-Afonso, T Mourez, R Lefaucheur. Invasive meningoencephalitis as the first manifestation of hepatitis A. J Viral Hepat, in press.

4-       L Izquierdo, G Mellon, C Buchaillet, C Fac, MP Soutière, C Pallier, A Dulioust, AM Roque-Afonso. Prevalence of hepatitis E virus and reassessment of HIV and other hepatitis virus seroprevalences among French prison inmates. PlosOne, in press

5-       T Enkirch, E Severi, H Vennema, L Thornton, J Dean, ML Borg, AR Ciccaglione, R Bruni, I Christova, SL Ngui, K Balogun, V Němeček, M Kontio, M Takács, A Hettmann, R Korotinska, A Löve, A Avellón, M Muñoz-Chimeno, R de Sousa, D Janta, J Epštein, S Klamer, S W. Aberle, H Holzmann, K Mellou, J Lundberg Ederth, L Sundqvist, AM Roque-Afonso, S Kurečić Filipović, M Poljak, L Vold, K Stene-Johansen, S Midgley, T Kølsen Fischer, M Faber, JJ Wenzel, J Takkinen, K Leitmeyer. Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus. EuroSurveill in press

6-       P Ndumbi, G. S. Freidl, C. Williams, O. Mardh, C. Varela, A. Avellón, I. Friesema, H. Vennema, K. Beebeejaun , S. L. Ngui, M. Edelstein, A. Smith-Palmer, N. Murphy, J. Dean, M. Faber, J. Wenzel, M. Kontio, L. Müller, S. Midgley, L. Sundqvist, J. Ederth, A. Roque-Afonso, E. Couturier, S. Klamer, J. Rebolledo, V. Suin, S. W. Aberle, D. Schmid, R. de Sousa, G. F. Augusto, V. Alfonsi, M. Del Manso, A. Ciccaglione, K. Mellou, C. Hadjichristodoulou, A. Donachie, M. Borg, M. Sočan, M. Poljak, Ettore Severi and The European Hepatitis A outbreak team. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area (EU/EEA), June 1st 2016 – May 31st 2017. Eurosurveill. 2018 Aug; 23(33). doi: 10.2807/1560-7917.ES.2018.23.33.1700641

7-       E Bouthry, A Benachi, AJ Vivanti, E Letamendia, C Vauloup-Fellous, AM Roque-Afonso. Mild course of autochthonous Hepatitis E during pregnancy in France. Emerg Infect Dis. 2018 Aug;24(8):1586-1587. doi:10.3201/eid2408.180105

8-       Gallian P, Barlet V, Mouna L, Gross S, Le Cam S, Ricard C, Wind F, Pouchol E, Fabra C, Flan B, Visse C, Djoudi R, Couturier E, De Valk H, Tiberghien P, Roque-Afonso AM. Hepatitis A: an epidemiological survey in blood donors, France 2015-2017. Eurosurveill. 2018;23(21):pii=1800237. https://doi.org/10.2807/1560-7917.ES.2018.23.21.1800237

9-       M Kaiser, D Delaune, O Chazouillères, J Blümel, AM Roque-Afonso, S. A. Baylis. A World Health Organization human hepatitis E virus reference strain related to similar strains isolated from rabbits. Genome Announc. 2018 Apr 19;6(16). pii: e00292-18. doi: 10.1128/genomeA.00292-18 8.R Sberro, AM Roque-Afonso, A Vallet-Pichard, B Deau-Fischer, A Portal, ML Chaix, L Hauser, A Beyloune, A Mercadier, J Izopet, C Legendre, S Pol, V Mallet. Transmission of hepatitis E virus with plasma exchange in kidney-transplant recipients: a retrospective cohort study. Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002185. [Epub ahead of print

10-    Todesco E, Mazzola A, Akhavan S, Abravanel F, Poynard T, Roque-Afonso AM, Peytavin G, Marcelin AG, Calmus Y, Lecuyer L, Guillemain R, Conti F. Chronic Hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective. Antivir Ther. 2018 Mar 5. doi: 10.3851/IMP3227

 

11-    Marion O, Abravanel F, Izopet J, Kamar N. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transpl Infect Dis. 2019 Jan 21:e13050.

12-    Marion O, Capelli N, Lhomme S, Dubois M, Pucelle M, Abravanel F, Kamar N, Izopet J. Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients. J Infect. 2019 Mar;78(3):232-240.

13-    Marion O, Lhomme S, Abravanel F, Izopet J, Kamar N.Should 12 or 24 weeks post-ribavirin follow-up be considered to define sustained virological response in transplant-patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 Mar 12:e13065.

14-    Abravanel F, Goutagny N, Joffray R, Eichenlaub E, Baron S, Aversenq A, Bourg S, Mercier L, Larue Triolet A, Poirault D, Loubet M, Daniel S, Luciani F, Pothion C, Tourneur C, Dugua JM, Lhomme S, Izopet J. Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.J Clin Virol. 2019 Mar;112:10-14

15-    Marion O, Lhomme S, Del Bello A, Abravanel F, Esposito L, Hébral AL, Lavayssière L, Cointault O, Ribes D, Izopet J, Kamar N. Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 Jan;70(1):206-209.

16-    Capelli N, Marion O, Dubois M, Allart S, Bertrand-Michel J, Lhomme S, Abravanel F, Izopet J, Chapuy-Regaud S.Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes. J Virol. 2019 Feb 5;93(4).

17-    S. Lhomme, F. Abravanel, N. Kamar, J. Izopet. Screening, diagnosis and risks associated with Hepatitis E infection. Expert Review of Anti-Infective Therapy 2019;17:403-418.

18-    C. Diméglio, D. Kania, J. Mbombi Mantono, T. Kagoné, S. Zida, S. Tassembedo, A. Dicko, B. Tinto, S. Yaro, H. Hien, J. Rouamba, B. Bicaba, I. Medah, N. Meda, O. Traoré, E. Tuaillon, F. Abravanel, J. Izopet. Hepatitis E virus infections among patients with acute febrile jaundice in Burkina Faso. Viruses 2019;554:1-9.

19-    J. Izopet, P. Trémeaux, O. Marion, M. Migueres, N. Capelli, S. Chapuy-Regaud, JM. Mansuy, F. Abravanel, N. Kamar, S. Lhomme. Hepatitis E virus infections in Europe. Journal of Clinical Virology 2019;120:20-26.

20-    P. Gallian, E. Pouchol, R. Djoudi, S. Lhomme, L. Mouna, S. Gross, P. Bierling, A. Assal, N. Kamar, V. Mallet, AM. Roque-Afonso, J. Izopet, P. Tiberghien. Transfusion-transmitted hepatitis E virus infection in France. Transfusion Medicine Reviews 2019;33:146-153.

21-    S. Lhomme, S. DebRoy, N. Kamar, F. Abravanel, D. Metsu, O. Marion, C. Dimeglio, SJ. Cotler, J. Izopet, H. Dahari. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses  2019;11:7.

22-    S. Lhomme, P. Gallian, C. Diméglio, F. Abravanel, P. Tiberghein, J. Izopet. Viral load and clinical manifestations of hepatitis E virus genotype 3 infections. J  Viral Hepatitis 2019;26:1139-1142.

23-    IM. Sayed, L. Verhoye, C. Montpellier, F. Abravanel, J. Izopet, L. Cocquerel, P. Meuleman. Study of hepatitis E virus ORF2 antigen kinetics in human-liver chimeric mice and its impact on HEV diagnosis. Journal of Infectious Diseases 2019;220:811-819.

24-    A. Del Bello, F. Abravanel, L. Alric, L. Lavayssière, S. Lhomme, J. Bellière, J. Izopet, N. Kamar. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents. Transplant Infectious Disease 2019;21:e13093.

25-    A. Xhaard, AM. Roque-Afonso, V. Mallet, P. Ribaud, S. Nguyen-Quoc, PS. Rohrlich, R. Tabrizi, J. Konopacki, S. Lissandre, F. Abravanel, RP. Latour, A. Huynh. Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study. Viruses 2019;11(7).

26-    Protin, F. Abravanel, L. Alric, S. Tavitian, L. Obéric, J. Izopet, G. Martin-Blondel, L. Ysebaert. Ribavirin for chronic Hepatitis E virus infection in ibrutinib-exposed patients. Open Forum Infect Dis 2019;6:ofz345.

27-    I.B. Olsoy, S. Henriksen, F.H. Weissbach, M. Larsen, K. Borgen, F. Abravanel, N. Kamar, E.J. Paulssen, H.H. Hirsch, C.H. Rinaldo. Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromso study. Med Microbiol Immunol, 2019, 208 :715-725

28-    N. Capelli, M. Dubois, M. Pucelle, I. Da Silva, S. Lhomme, F. Abravanel, S. Chapuy-Regaud, J. Izopet. Optimized HEV culture and its application to measurements of HEV infectivity. Viruses 2020;12:1-11.

29-    S. Lhomme, O. Marion, F. Abravanel, J. Izopet, N. Kamar. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. Journal of Clinical Medicine 2020;9:1-25.

30-    L. Capai, N. Hozé, J. Chiaroni, S. Gross, R. Djoudi, R. Charrel, J. Izopet, S. Priet, S. Cauchemez, X. De Lamballerie, A. Falchi, P. Gallian. Seroprevalence and quantification of antibodies anti-HEV IgG among blood donors in Corsica, France, 2017. Eurosurveillance 2020; 25:pii=1900336.

31-    H. Larrue, F. Abravanel, JM. Péron. Hepatitis E, what’s the real issue? Liver International 2020;Suppl 1:43-47.

32-    S. Lhomme, F. Nicot, N. Jeanne, A. Roulet, C. Lefèbvre, R. Carcenac, M. Manno, M. Dubois, JM. Péron, L. Alric, N. Kamar, F. Abravanel, J. Izopet. Insertions and duplications in the polyproline region of the hepatitis E virus. Frontiers in Microbiology 2020;11:1.

33-    F. Abravanel, C. Diméglio, M. Castanier, JM. Péron, N. Kamar, S. Lhomme, J. Izopet on behalf of the HEV study group. Does HEV-3 subtype play a role in the severity of acute hepatitis E? Liver International 2020;40:333-337.

34-    N. Kamar, F. Abravanel, P. Behrendt, J. Hofmann, GP. Pageaux, C. Barbet, V. Moal, L. Couzi, T. Horvatits, RA. De Man, E. Cassuto, AM. Elsharkawy, A. Riezebos-Brilman, A. Scemla, S. Hillaire, MC. Donnely, S. Radenne, J. Sayegh, C. Garrouste, J. Dumortier, F. Glowaki, M. Matignon, A. Coilly, L. Figueres, C. Mousson, A. Minello, S. Dharancy, JP. Rerolle, P. Lebray, I. Etienne, P. Perrin, M. Choi, O. Marion, J. Izopet. Ribavirin for hepatitis E virus infection after organ transplantation: a large European retrospective multicenter study. Clinical Infectious Diseases 2019, sous presse.

35-    O. Marion, S. Lhomme, M. Nayrac, M. Dubois, M. Pucelle, M. Requena, M. Migueres, F. Abravanel, JM. Péron, N. Carrère, B. Suc, P. Delobel, N. Kamar, J. Izopet. Hepatitis E virus replication in human intestinal cells. Gut, 2019, sous presse.

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=131295 0 Publications 2017 http://www.cnrvha-vhe.org/?p=131279 http://www.cnrvha-vhe.org/?p=131279#comments Fri, 04 Oct 2019 08:03:04 +0000 Toulouse http://www.cnrvha-vhe.org/?p=131279 C. Renou, B. Lesgourgues, G. Macaigne, A. Pauwels, Y. Le Bricquir, J. Henrion, F. Khemissa, E. Clair, T. Paupard, A. Pelaquier, H. Agostini, A.M. Roque-Afonso. Hepatitis E in decompensated alcoholic cirrhosis. Hepatology 2017 Jan;65(1):388-389. doi: 10.1002/hep.28792

H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017

P Ndumbi, G. S. Freidl, C. Williams, O. Mardh, C. Varela, A. Avellón, I. Friesema, H. Vennema, K. Beebeejaun , S. L. Ngui, M. Edelstein, A. Smith-Palmer, N. Murphy, J. Dean, M. Faber, J. Wenzel, M. Kontio, L. Müller, S. Midgley, L. Sundqvist, J. Ederth, A. Roque-Afonso, E. Couturier, S. Klamer, J. Rebolledo, V. Suin, S. W. Aberle, D. Schmid, R. de Sousa, G. F. Augusto, V. Alfonsi, M. Del Manso, A. Ciccaglione, K. Mellou, C. Hadjichristodoulou, A. Donachie, M. Borg, M. Sočan, M. Poljak, Ettore Severi and The European Hepatitis A outbreak team.  Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area (EU/EEA), June 1st 2016 – May 31st 2017. Eurosurveill.

Alnuaimi K, Lavolé J, Lascoux-Combes C, Roque-Afonso AM, Sogni P, Pol S, Mallet V. Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine. Hepatology, 2017 Dec 1. doi: 10.1002/hep.29697. [Epub ahead of print].

Bisseux M, Colombet J, Mirand A, Roque-Afonso AM, Abravanel F, Izopet J, Archimbaud C, Peigue-Lafeuille H, Debroas D, Bailly JL, Henquell C. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: results of a one-year experiment in Central France, 2014-2015. Eurosurveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00237

Charre C, Ramière C, Roque-Afonso AM, Chidiac C, Zoulim F, Godinot M, Koffi J, Scholtès C, Livrozet JM, HAV Lyon Study Group, Cotte L. HAV outbreak in French HIV-infected MSM and PrEP users despite a high immunization rate. Eurosurveill. Euro Surveill. 2017 Nov;22(48). doi: 10.2807/1560-7917.ES.2017.22.48.17-00742

Mallet V, Bruneau J, Zuber J, Alanio C, Leclerc-Mercier S, Roque-Afonso AM, Kraft ARM, Couronné L, Roulot D, Wedemeyer H, Albert ML, Hillon P, Laroche L, Pol S, Hermine O.Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder. J Hepatol. 2017 Aug 28. pii: S0168-8278(17)32250-X. doi: 10.1016/j.jhep.2017.08.011

Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V. Chronic hepatitis E in HIV/HBV coinfectde patient: lack of power of sofosbuvir-ribavirin. AIDS. 2017 Jun 1;31(9):1346-1348.

H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017 Apr 20;12(4):e0175887. doi: 10.1371/journal.pone.0175887. eCollection 2017.

S. Lhomme, L. Bardiaux, F. Abravanel, P. Gallian, N.Kamar, J. Izopet. Hepatitis E virus infection in solid organ transplant recipients, France. Emerging Infectious Diseases 2017;23:353-356.

M. Carré, A. Thiebaut-Bertrand, S. Larrat, V. Leroy, P. Pouzol, N. Sturm, S. Lhomme, JY. Cahn, F. Garban, P. Morand. Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation. Bone Marrow Transplantation 2017;1-3.

Donnelly MC, SN. Imlach, F. Abravanel, S. Ramalingam, I. Johannessen, J. Petrik, AR. Fraser, JD. Campbell, P. Bramley, HR. Dalton, PC. Hayes, N. Kamar, KJ. Simpson. Sofosbuvir and Daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV/HCV co-infected liver transplant recipient. Gastroenterology 2017;152:300-301.

Abravanel F, S. Lhomme, M. Fougère, K. Sauné, M. Alvarez, JM. Péron, P. Delobel, J. Izopet. HEV infection in French HIV-infected patients. Journal of Infection 2017;74:310-313.

Abravanel F, N. Goutagny, C. Perret, S. Lhomme, F. Vischi, A. Aversenq, A. Chapel, N. Dehainault, N. Piga, J. Dupret-Carruel, J. Izopet. Evaluation of two VIDASÒ prototypes for detecting anti-HEV IgG. Journal of Clinical Virology 2017;89:46-60.

HR. Dalton, JJJ. Van Eijk, P. Cintas, RG. Madden, CJ. Jones, GW. Webb, B. Norton, J. Pique, S. Lutgens, N. Devooght-Johnson, K. Woolson, J. Baker, M. Saunders, L. Househam, J. Griffiths, F. Abravanel, J. Izopet, N. Kamar, N. van Alfen, BG. Van Engelen, JG. Hunter, AA. van der Eijk, RP. Bendall, BN. Mclean, BC. Jacobs. Hepatitis E virus infection and acute non-traumatic neurological injury: a prospective pilot multicentre study. Journal of Hepatology 2017;67:925-932.

J. Belliere, F. Abravanel, MB. Nogier, S. Martinez, P. Cintas, S. Lhomme, L. Lavayssière, O. Cointault, S. Faguer, J. Izopet, N. Kamar. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart-transplant patient. Transplant Infectious Disease 2017;19:6.

A Velay, W. Kack-Kack, F. Abravanel, S. Lhomme, P. Leyendecker, L. Kremer, P. Chamouard, J. Izopet, S. Fafi-Kremer, H. Barth. Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient. Journal of Neurovirology 2017;23:615-620.

S. Chapuy-Regaud, M. Dubois, C. Plisson-Chastang, T. Bonnefois, S. Lhomme, J. Bertrand-Michel, B. You, S. Simoneau, PE. Gleizes, B. Flan, F. Abravanel, J. Izopet. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response. Biochimie 2017;141:70-79.

JJJ. van Eijk, HR. Dalton, P. Ripellino, RG. Madden, CJE. Jones, M. Fritz, C. Gobbi, G. Melli, E. Pasi, J. Herrod, RF. Lissmann, HH. Ashraf, M. Abdelrahim, O. Almasri, M. Fraga, D. Benninger, T. Kuntzer, V. Aubert, R. Sahli, D. Moradpour, H. Blasco-Perrin, S. Attarian, R. Gerolami, P. Colson, MT. Giordani, J. Hartl, S. Pischke, NX. Lin, BN. Mclean, RP. Bendall, M. Panning, JM. Peron, N. Kamar, J. Izopet, BC. Jacobs, N. van Alfen, BGM. van Engelen. Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international multicenter retrospective comparative study. Neurology 2017:909-917.

F. Abravanel, S. Lhomme, H. El Costa, B. Schvartz, JM. Peron, N. Kamar, J. Izopet. Rabbit Hepatitis E virus infections in humans, France. Emerging Infectious Diseases 2017;23:1191-1193.

H. Barragué, B. Condat, N. Petitdidier, E. Champagne, C. Renou, J. Izopet, F. Abravanel. Chronic hepatitis E virus infection in a cirrhotic patient: a case report. Medicine 2017;96 :e7915.

IM Sayed, L. Foquet, L. Verhoye, F. Abravanel, A. Farhoudi, G. Leroux-Roels, J. Izopet, P. Meuleman. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Research 2017 141:150-154.

IM. Sayed, L. Verhoye, L. Cocquerel, F. Abravanel, L. Foquet, C. Montpellier, Y. Debing, A. Farhoudi, C. Wychowski, J. Dubuisson, G. Leroux-Roels, J. Neyts, J. Izopet, T. Michiels, P. Meuleman. Study of Hepatitis E virus infection of genotype 1 and 3 in mice with humanized liver. Gut 2017;66:920-929.

N. Kamar, J. Izopet, N. Pavio, R. Agarwal, A. Labrique, H. Wedemeyer, H. Dalton. Hepatitis E virus infection. Nature Reviews Disease Primers 2017;3 :17086

X. Yin, X. Li, C. Ambardekar, Z. Hu, S. Lhomme, Z. Feng. Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog. 2017 May 30;13(5):e1006417.

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=131279 0 Publications 2016 http://www.cnrvha-vhe.org/?p=131272 http://www.cnrvha-vhe.org/?p=131272#comments Fri, 04 Oct 2019 07:50:43 +0000 Toulouse http://www.cnrvha-vhe.org/?p=131272 V Mallet; R Sberro-Soussan, A Vallet-Pichard, AM Roque-Afonso, S Pol. Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report. Ann Intern Med 2016, 21;164(12):851-2. doi: 10.7326/L15-0502.

Pourbaix A, Ouali N, Soussan P, Roque-Afonso AM, Péraldi MN, Rondeau E, Peltier J. Evidence of hepatitis E virus transmission by renal graft. Transpl Infect Dis. 2016 Oct 24. doi: 10.1111/tid.12624

De Martin E, Antonini TM, Coilly A, Pittau G, Vibert E, Duclos-Vallée JC, Samuel D, Roque-Afonso AM. HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses. Transplant International Transpl Int. 2016 Nov 29. doi: 10.1111/tri.12898

R. Boudjellil, M. Elbaz, O. Lairez, J. Izopet, N. Kamar. No evidence of genotype-3 hepatitis E virus-induced myocarditis. Journal of Clinical Virology 2016;76:44.

Y. Guillois, F. Abravanel, T. Miura, N. Pavio, V. Vaillant, S. Lhomme, F.S. Le Guyader, N. Rose, JC. Le Saux, L. King, J. Izopet, E. Couturier. High proportion of asymptomatic infections in an outbreak of hepatitis E associated with a spit-roasted piglet, France, 2013. Clinical Infectious Diseases 2016;62:351-357.

J. Petrik, M. Lozano, CR. Seed, HM. Faddy, AJ. Keller, PS. Prado Scuracchio, S. Wendel, A. Andonov, M. Fearon, G. Delage, J. Zhang, JW. Shih, P. Gallian, R. Djoudi, P. Tiberghein, J. Izopet, J. Dreier, T. Vollmer, C. Knabbe, R. Aggarwal, A. Goel, AR. Ciccaglione, K. Matsubayashi, M. Satake, K. Tadokoro, SH. Jeong, HL. Zaaijer, E. Zhiburt, J. Chay, D. Teo, SS. Chua, M. Piron, S. Sauleda, JM. Echevarria, H. Dalton, SL. Stramer. Hepatitis E. Vox Sanguinis 2016;110 :93-103.

N. Kamar, O. Marion, J. Izopet. When should ribavirin be started to treat hepatitis E virus infection in transplant-patients? American Journal of Transplantation 2016;16:727.

JM. Péron, F. Abravanel, M. Guillaume, R. Gérolami, J. Nana, R. Anty, A. Pariente, C. Renou, C. Bureau, MA. Robic, L. Alric, JP. Vinel, J. Izopet, N. Kamar. Treatment of autochtonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver International 2016;36:328-333.

P. Trémeaux, S. Lhomme, S. Chapuy-Regaud, JM. Peron, L. Alric, N. Kamar, J. Izopet, F. Abravanel. Performance of an antigen assay for the diagnosis of acute hepatitis E virus infection. Journal of Clinical Virology 2016;79:1-5.

Guinault D, Ribes D, Delas A, Milongo D, Abravanel F, Puissant-Lubrano B, Izopet J, Kamar N. Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person.Am J Kidney Dis. 2016 Apr;67(4):660-3

Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J, Champagne E. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. J Infect. 2016 :723-30.

Smith DB, Simmonds P, Izopet J, Oliveira-Filho EF, Ulrich RG, Johne R, Koenig M, Jameel S, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. Proposed reference sequences for hepatitis E virus subtypes.J Gen Virol. 2016 Mar;97(3):537-42

Mansuy JM, Gallian P, Dimeglio C, Saune K, Arnaud C, Pelletier B, Morel P, Legrand D, Tiberghien P, Izopet J.A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology. 2016 Apr;63(4):1145-54

Servant-Delmas A, Abravanel F, Lefrère JJ, Lionnet F, Hamon C, Izopet J, Laperche S. New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France. J Viral Hepat. 2016 Jul;23(7):569-75.

Miura T, Lhomme S, Le Saux JC, Le Mehaute P, Guillois Y, Couturier E, Izopet J, Abravanel F, Le Guyader FS. Detection of hepatitis E virus in sewage after an outbreak on a French Island. Food and Environmental Virology 2016 ;8 :194-199.

Sayed IM, Verhoye L, Cocquerel L, Abravanel F, Foquet L, Montpellier C, Debing Y, Farhoudi A, Wychowski C, Dubuisson J, Leroux-Roels G, Neyts J, Izopet J, Michiels T, Meuleman P.Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut. 2016 Ma 22

Nicot F, M. Cazabat, S. Lhomme, O. Marion, K. Sauné, J. Chiabrando, M. Dubois, N. Kamar, F. Abravanel, J. Izopet. Quantification of HEV RNA by Droplet Digital PCR. Viruses 2016;8:8.

A.Brown, JS. Halliday, L. Swadling, R. Madden, R. Bendall, JG. Hunter, J. Maggs, P. Simmonds, DB. Smith, L. Vine, C. McLaughlin, J. Collier, K. Jeffery, P. Klenerman, J. Izopet, N. Kamar, HR. Dalton, E. Barnes. Characterisation of the specificity, functionality and durability of host T-cell responses against the full-length hepatitis E virus. Hepatology 2016 ;64:1934-1950.

 

Revues:

 

Marion O, Abravanel F, Lhomme S, Izopet J, Kamar N. Hepatitis E in transplantation. Curr Infect Dis Rep 2016:18:8.

Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver Int 2016;36:467-72.

Blasco-Perrin H, Abravanel F, Blasco-Baque V, Péron JM. Hepatitis E, the neglected one. Liver Int 2016 Jan;36 Suppl 1:130-4.

N. Kamar, O. Marion, J. Izopet. When should ribavirin be started to treat hepatitis E virus infection in transplant-patients? American Journal of Transplantation 2016;16:727.

Kamar N, S. Lhomme, F. Abravanel, O. Marion, JM. Péron, L. Alric, J. Izopet. Treatment of HEV infection in patients with a solid-organ transplant and chronic hepatitis. Viruses 2016;8:8.

S. Lhomme, O. Marion, F. Abravanel, S. Chapuy-Regaud, N. Kamar, J. Izopet. Hepatitis E pathogenesis. Viruses 2016;8:8.

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=131272 0 Publications 2015 http://www.cnrvha-vhe.org/?p=144 http://www.cnrvha-vhe.org/?p=144#comments Fri, 27 Nov 2015 18:17:47 +0000 Anne Marie Roque-afonso http://www.cnrvha-vhe.org/?p=144 Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France.Lhomme S, Abravanel F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.Infect Genet Evol. 2015 Oct;35:50-5. doi: 10.1016/j.meegid.2015.07.028. Epub 2015 Jul 26.

Treatment of autochthonous acute hepatitis e with short term ribavirin: a multicenter retrospective study. Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N. Liver Int. 2015 Jul 14. doi: 10.1111/liv.12911.

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse.Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J.Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742.

Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J.Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005.

[Treatment of hepatitis E virus infection]. Kamar N, Rostaing L, Alric L, Peron JM, Izopet J.Presse Med. 2015 Mar;44(3):339-42. doi: 10.1016/j.lpm.2014.10.011. Epub 2015 Jan 29. Review. French.

[Hepatitis E virus]. Izopet J, LhommeS, Abravanel F, Roque AM, Kamar N. Presse Med. 2015 Mar;44(3):328-32. doi: 10.1016/j.lpm.2014.11.004. Epub 2015 Jan 30. Review. French

Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin. Del Bello A, Guilbeau-Frugier C, Josse AG, Rostaing L, Izopet J, Kamar N.Transpl Infect Dis. 2015 Apr;17(2):279-83. doi: 10.1111/tid.12353. Epub 2015 Feb 24

Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, Chatelus E, Claudepierre P, Hudry C, Izopet J, Fabre S, Lefevre G, Marguerie L, Martin A, Messer L, Molto A, Pallot-Prades B, Pers YM, Roque-Afonso AM, Roux C, Sordet C, Soubrier M, Veissier C, Wendling D, Péron JM, Sibilia J; Club Rhumatismes et Inflammation, a section of the French Society of Rheumatology. Medicine (Baltimore). 2015 Apr;94(14):e675. doi: 10.1097/MD.0000000000000675.

Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.Mansuy JM, Saune K, Rech H, Abravanel F, Mengelle C, L Homme S, Destruel F, Kamar N, Izopet J.Euro Surveill. 2015 May 14;20(19):27-34.

Wildlife Reservoir for Hepatitis E Virus, Southwestern France.Lhomme S, Top S, Bertagnoli S, Dubois M, Guerin JL, Izopet J.Emerg Infect Dis. 2015 Jul;21(7):1224-6. doi: 10.3201/eid2107.141909.

Treatment of autochthonous acute hepatitis e with short term ribavirin: a multicenter retrospective study. Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N.Liver Int. 2015 Jul 14. doi: 10.1111/liv.12911.

Hepatitis E. Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL.Vox Sang. 2015 Jul 21. doi: 10.1111/vox.12285.

An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients.Kamar N, Lhomme S, Abravanel F, Cointault O, Esposito L, Cardeau-Desangles I, Del Bello A, Dörr G, Lavayssière L, Nogier MB, Guitard J, Ribes D, Goin AL, Broué P, Metsu D, Sauné K, Rostaing L, Izopet J.Transplantation. 2015 Oct;99(10):2124-31. doi: 10.1097/TP.0000000000000850.

Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France.Lhomme S, Abravanel F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.Infect Genet Evol. 2015 Oct;35:50-5. doi: 10.1016/j.meegid.2015.07.028. Epub 2015 Jul 26.

Variability and pathogenicity of hepatitis E virus genotype 3 variants.Smith DB, Ijaz S, Tedder RS, Hogema B, Zaaijer HL, Izopet J, Bradley-Stewart A, Gunson R, Harvala H, Kokki I, Simmonds P.J Gen Virol. 2015 Nov;96(11):3255-64. doi: 10.1099/jgv.0.000264. Epub 2015 Aug 14.

Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.Izopet J, Labrique AB, Basnyat B, Dalton HR, Kmush B, Heaney CD, Nelson KE, Ahmed ZB, Zaman K, Mansuy JM, Bendall R, Sauné K, Kamar N, Arjyal A, Karkey A, Dongol S, Prajapati KG, Adhikary D. J Clin Virol. 2015 Sep;70:39-42. doi: 10.1016/j.jcv.2015.06.103. Epub 2015 Jun 29.

Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. J Clin Virol. 2015 Sep;70:101-4. doi: 10.1016/j.jcv.2015.07.302. Epub 2015 Jul 26

High Proportion of Asymptomatic Infections in an Outbreak of Hepatitis E Associated With a Spit-Roasted Piglet, France, 2013. Guillois Y, Abravanel F, Miura T, Pavio N, Vaillant V, Lhomme S, Le Guyader FS, Rose N, Le Saux JC, King LA, Izopet J, Couturier E.Clin Infect Dis. 2015 Oct 1. pii: civ862.

Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Perrin HB, Cintas P, Abravanel F, Gérolami R, d’Alteroche L, Raynal JN, Alric L, Dupuis E, Prudhomme L, Vaucher E, Couzigou P, Liversain JM, Bureau C, Vinel JP, Kamar N, Izopet J, Peron JM. Emerg Infect Dis. 2015 Nov;21(11). doi: 10.3201/eid2111.141789. No abstract available.

Hepatitis E virus in hematopoietic stem cell donors: Towards a systematic HEV screening of donors? Frange P, Roque-Afonso AM, Neven B, Moshous D, Touzot F, Cavazzana M, Fischer A, Leruez-Ville M, Blanche S.J Infect. 2015 Jul;71(1):141-4. doi: 10.1016/j.jinf.2015.02.008. Epub 2015 Feb 26.

Multistate foodborne hepatitis A outbreak among European tourists returning from Egypt–need for reinforced vaccination recommendations, November 2012 to April 2013. Sane J, MacDonald E, Vold L, Gossner C, Severi E; Outbreak Investigation Team.Euro Surveill. 2015 Jan 29;20(4). pii: 21018.

Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014. Severi E, Verhoef L, Thornton L, Guzman-Herrador BR, Faber M, Sundqvist L, Rimhanen-Finne R, Roque-Afonso AM, Ngui SL, Allerberger F, Baumann-Popczyk A, Muller L, Parmakova K, Alfonsi V, Tavoschi L, Vennema H, Fitzgerald M, Myrmel M, Gertler M, Ederth J, Kontio M, Vanbockstael C, Mandal S, Sadkowska-Todys M, Tosti ME, Schimmer B, O Gorman J, Stene-Johansen K, Wenzel JJ, Jones G, Balogun K, Ciccaglione AR, O’ Connor L, Vold L, Takkinen J, Rizzo C. Euro Surveill. 2015 Jul 23;20(29):21192.

 

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=144 0 Publications 2014 http://www.cnrvha-vhe.org/?p=117 http://www.cnrvha-vhe.org/?p=117#comments Sun, 23 Feb 2014 15:04:17 +0000 Anne Marie Roque-afonso http://www.cnrvha-vhe.org/?p=117  

Hepatitis E in developed countries: current status and future perspectives. Dalton HR, Kamar N, Izopet J.Future Microbiol. 2014;9(12):1361-72. doi: 10.2217/fmb.14.89. Review.

Hepatitis E virus infections in blood donors, France.Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F, Assal A, Tiberghien P, Izopet J.Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.

[Hepatitis E virus: Blood transfusion implications].Gallian P, Piquet Y, Assal A, Djoudi R, Chiaroni J, Izopet J, Tiberghien P.Transfus Clin Biol. 2014 Nov;21(4-5):173-7. doi: 10.1016/j.tracli.2014.07.007. Epub 2014 Sep 27. Review. French.

Hepatitis A virus subgenotyping based on RT-qPCR assays. Coudray-Meunier C, Fraisse A, Mokhtari C, Martin-Latil S, Roque-Afonso AM, Perelle S.BMC Microbiol. 2014 Nov 25;14:296. doi: 10.1186/s12866-014-0296-1.

Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742. Epub 2014 Sep 23

Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005. Epub 2014 Aug 21

Safety measures to prevent hepatitis E virus transmission by blood transfusion. Laperche S, Izopet J, Lefrère JJ. Transfusion. 2014 Aug;54(8):2134-5. doi: 10.1111/trf.12735.

Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients.Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.J Virol. 2014 Oct;88(20):12017-25. doi: 10.1128/JVI.01625-14. Epub 2014 Aug 6.

Ribavirin for chronic hepatitis E virus infection. Kamar N, Mallet V, Izopet J. N Engl J Med. 2014 Jun 19;370(25):2447-8. doi: 10.1056/NEJMc1405191.

Hepatitis E infection in patients with severe acute alcoholic hepatitis. Haim-Boukobza S, Coilly A, Sebagh M, Bouamoud M, Antonini T, Roche B, Yordanova O, Savary J, Saliba F, Duclos-Vallee JC, Samuel D, Ichai P, Roque-Afonso AM. Liver Int. 2015 Mar;35(3):870-5. doi: 10.1111/liv.12610.

Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin. Robbins A, Lambert D, Ehrhard F, Brodard V, Hentzien M, Lebrun D, Nguyen Y, Tabary T, Peron JM, Izopet J, Bani-Sadr F. J Clin Virol. 2014 Aug;60(4):422-3. doi: 10.1016/j.jcv.2014.05.003. Epub 2014 May 13

Ribavirin for chronic hepatitis E virus infection in transplant recipients.Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V.N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.

Does chronic hepatitis E virus infection exist in immunocompetent patients? Kamar N, Izopet J. Hepatology. 2014 Jul;60(1):427. doi: 10.1002/hep.26927. Epub 2014 May 27.

Prospective study of Hepatitis E Virus infection among pregnant women in France. Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM; Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux (ANGH). Virol J. 2014 Apr 9;11:68. doi: 10.1186/1743-422X-11-68

Hepatitis E: An emerging infection in high income countries. Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, Salmon D. J Clin Virol. 2014 Feb;59(2):81-8.

Should we screen blood products for hepatitis E virus RNA ? Féray C, Pawlotsky JM, Roque-Afonso AM, Samuel D, Dhumeaux D. Lancet. 2014 Jan 18;383(9913):218.

Biphasic hepatitis A with severe cholestasis and thrombocytopenic purpura in an HIV-1-infected male patient. Bani-Sadr F, Chakvetadze C, Galperine T, Lassel L, Bonnard P, Lependeven C, Roque-Afonso AM, Pialoux G. Med Mal Infect. 2014 Jan 13. pii: S0399-077X(13)00341-7.

Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Hauser L, Roque-Afonso AM, Beylouné A, Simonet M, Deau Fischer B, Burin des Roziers N, Mallet V, Tiberghien P, Bierling P. Blood. 2014 Jan 30;123(5):796-7.

Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve to chronic infections. Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Kamar N, Izopet J. J Infect Dis. 2014 Jan 16.

Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J. J Infect Dis. 2014 Jan 15;209(2):300-3.

Hepatitis E virus infection. Kamar N, Dalton HR, Abravanel F, Izopet J. Clin Microbiol Rev. 2014 Jan;27(1):116-38.

 

]]> http://www.cnrvha-vhe.org/?feed=rss2&p=117 0 Actualités http://www.cnrvha-vhe.org/?p=24 http://www.cnrvha-vhe.org/?p=24#comments Sun, 29 Sep 2013 19:40:29 +0000 admin http://localhost/cnrvhavhe/?p=24
  • Surveillance de l’hépatite E en France 2002-2016 Article publié dans le BEH le 11 septembre 2018
    • La transmission de l’hépatite E par transfusion: ce que nous apportent les déclarations. Point de l’ANSM sur son bulletin de juillet 2013 (p.10). Bulletin des Vigilances n° 58.
    ]]>     http://www.cnrvha-vhe.org/?feed=rss2&p=24 0     Publications 2013 http://www.cnrvha-vhe.org/?p=101 http://www.cnrvha-vhe.org/?p=101#comments Sat, 11 May 2013 10:02:29 +0000 Anne Marie Roque-afonso http://www.cnrvha-vhe.org/?p=101 Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. J Clin Virol. 2013 Dec;58(4):624-8.

    Chronic hepatitis E infection cured by pregnancy. Mallet V, Le Mener S, Roque-Afonso AM, Tsatsaris V, Mamzer MF. J Clin Virol. 2013 Dec;58(4):745-7.

    Does chronic hepatitis E virus infection exist in immunocompetent patients? Kamar N, Izopet J. Hepatology. 2013 Nov 9. doi: 10.1002/hep.26927.

    Hepatitis C virus infection in nephrology patients. Rostaing L, Izopet J, Kamar N. J Nephropathol. 2013 Oct;2(4):217-233.

    Comparison of real-time RT-PCR assays for hepatitis E virus RNA detection. Mokhtari C, Marchadier E, Haïm-Boukobza S, Jeblaoui A, Tessé S, Savary J, Roque-Afonso AM. J Clin Virol. 2013 Sep;58(1):36-40.

    [Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient.] Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. Rev Med Interne. 2013 Sep 27. pii: S0248-8663(13)00529-8.

    Genotype 4 hepatitis e virus in france: an autochthonous infection with a more severe presentation. Jeblaoui A, Haim-Boukobza S, Marchadier E, Mokhtari C, Roque-Afonso AM. Clin Infect Dis. 2013 Aug;57(4):e122-6.

    Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Coilly A, Haïm-Boukobza S, Roche B, Antonini TM, Pause A, Mokhtari C, Becq A, Farahmand H, Hauser L, Duclos-Vallée JC, Samuel D, Adam R, Roque-Afonso AM. Transplantation. 2013 Jul 27;96(2):e4-6.

    How Should Hepatitis E Virus Infection Be Defined in Organ-Transplant Recipients? Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J. Am J Transplant. 2013 May 9. doi: 10.1111/ajt.12253.

    An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G, Moradpour D, Abravanel F, Izopet J, Cavassini M, Darling KE. PLoS One. 2013 May 7;8(5):e62980.

    World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, Nübling CM, Hanschmann KM; HEV Collaborative Study Group. Emerg Infect Dis. 2013 May;19(5):729-35.

    Hepatitis E virus. Abravanel F, Lhomme S, Dubois M, Peron JM, Alric L, Kamar N, Izopet J. Med Mal Infect. 2013 Apr 19.

    Hepatitis e virus infection in immunosuppressed patients: natural history and therapy. Kamar N, Rostaing L, Izopet J. Semin Liver Dis. 2013 Feb;33(1):62-70.

    Performance of two commercial assays for detecting HEV RNA in acute or chronic infections. Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L,

    Rostaing L, Kamar N, Izopet J. J Clin Microbiol. 2013 Mar 20.

    Hepatitis E virus infection. Kamar N, Izopet J, Rostaing L. Curr Opin Gastroenterol. 2013 May;29(3):271-8.

    Risk of zoonotic transmission of HEV from rabbits. Lhomme S, Dubois M, Abravanel F, Top S, Bertagnoli S, Guerin JL, Izopet J. J Clin Virol. 2013 Mar 6.

     

     

     

    ]]>     http://www.cnrvha-vhe.org/?feed=rss2&p=101 0     publications 2012 http://www.cnrvha-vhe.org/?p=75 http://www.cnrvha-vhe.org/?p=75#comments Sat, 11 Aug 2012 06:44:00 +0000 admin http://www.cnrvha-vhe.org/?p=75 Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. Haïm-Boukobza S, Ferey MP, Vétillard AL, Jeblaoui A, Pélissier E, Pelletier G, Teillet L, Roque-Afonso AM. J Hepatol. 2012 Dec;57(6):1374-8.

    [Autochthonous hepatitis E: an emerging and still unrecognized disease]. Renou C, Pariente A, Roque-Afonso AM, Nicand E. Rev Prat. 2012 Sep;62(7):903-8.

    Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Izopet J, Dubois M, Bertagnoli S, Lhomme S, Marchandeau S, Boucher S, Kamar N, Abravanel F, Guérin JL. Emerg Infect Dis. 2012 Aug;18(8):1274-81.

    HEV Quasispecies and the Outcome of Acute Hepatitis E in Solid-Organ Transplant Patients. Lhomme S, Abravanel F, Dubois M, Sandres Saune K, Rostaing L, Kamar N, Izopet J.J Virol. 2012 Jul 3.

    Hepatitis E. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. Lancet. 2012 Jun 30;379(9835):2477-88.

    Hepatitis E Virus: What Transplant Physicians Should Know. Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Am J Transplant. 2012 Apr 30.

    Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Récher C, Izopet J. J Clin

    Virol. 2012 Jun;54(2):152-5.

    Hepatitis E virus and the kidney in solid-organ transplant patients. Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Transplantation. 2012 Mar 27;93(6):617-23.

    Genotype 3 diversity and quantification of hepatitis E virus RNA. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM, Izopet J. J Clin Microbiol. 2012 Mar;50(3):897-902.

    Hepatitis E virus-specific T-cell response after transplantation. Kamar N, Legrand-Abravanel F, Dalton HR, Izopet J. Hepatology. 2012 May;55(5):1643; author reply 1644.

    Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR, El-Daly M, Ibrahim EM, El-Aidy S, Lashin T, El-Hoseiny M, Izopet J, Mohamed MK, Fontanet A, Abdel Hamid M. Clin Microbiol Infect. 2012 Oct;18(10):982-8.

    ]]>     http://www.cnrvha-vhe.org/?feed=rss2&p=75 0     Nous contacter http://www.cnrvha-vhe.org/?p=42 http://www.cnrvha-vhe.org/?p=42#comments Sun, 01 Apr 2012 08:10:54 +0000 admin http://localhost/cnrvhavhe/?p=42 Hépatite A : Pr Roque-Afonso
    Laboratoire de Virologie Hôpital Paul Brousse
    12 av. Paul Vaillant-Couturier,  94804 villejuif
    Tel 0145593721
    Fax 0145593724
    anne-marie.roque@aphp.fr ou  cnr-vha.pbr@aphp.fr

     

    Hépatite E : Pr Izopet
    Laboratoire de Virologie Institut Fédératif de Biologie
    330 av. de Grande Bretagne, 31059 Toulouse cedex 9
    Tel 0567690424
    Fax 0567690425
    izopet.j@chu-toulouse.fr

    ]]>     http://www.cnrvha-vhe.org/?feed=rss2&p=42 0